Antenatal betamethasone therapy potentiates nitric oxide-mediated relaxation of preterm ovine coronary arteries

Am J Physiol. 1996 Feb;270(2 Pt 2):H538-44. doi: 10.1152/ajpheart.1996.270.2.H538.

Abstract

The present study was designed to test the hypothesis that betamethasone may potentiate nitric oxide-mediated relaxation of coronary arteries of preterm lambs. Isolated coronary arteries were obtained from lambs delivered at 128 days gestation. The lambs were treated intramuscularly with a single dose of betamethasone or saline 48 h before delivery and were killed after 3 h of ventilation after delivery. Vessel rings were suspended in organ chambers filled with modified Krebs-Ringer solution (95% O2-5% CO2, 37 degrees C), and their isometric tension was recorded. The endothelium-dependent relaxation induced by bradykinin and calcium ionophore A23187 was greater in arteries from antenatal betamethasone-treated lambs than in arteries from control lambs. The relaxation was abolished by N omega-nitro-L-arginine. Nitric oxide induced a greater relaxation in vessels from antenatal betamethasone-treated lambs and in vessels preincubated with betamethasone than in vessels from controls. Coronary arteries from control and antenatal betamethasone-treated lambs relaxed similarly to 8-bromoguanosine 3',5'-cyclic monophosphate. Nitric oxide induced a greater increase in guanosine 3',5'-cyclic monophosphate content in coronary arteries from antenatal betamethasone-treated lambs than in arteries from control lambs. Our data suggest that antenatal betamethasone therapy potentiates nitric oxide-mediated relaxation in coronary arteries from preterm lambs, probably by affecting the activity of soluble guanylate cyclase of vascular smooth muscle cells.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Arteries / drug effects
  • Arteries / embryology
  • Betamethasone / pharmacology*
  • Bradykinin / pharmacology
  • Calcimycin / pharmacology
  • Coronary Vessels / drug effects*
  • Coronary Vessels / embryology*
  • Cyclic GMP / analogs & derivatives
  • Cyclic GMP / metabolism
  • Cyclic GMP / pharmacology
  • Female
  • Fetus / physiology
  • Nitric Oxide / physiology*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitroarginine / pharmacology
  • Sheep / embryology
  • Vasodilation*

Substances

  • Nitroarginine
  • 8-bromocyclic GMP
  • Nitric Oxide
  • Calcimycin
  • Betamethasone
  • Nitric Oxide Synthase
  • Cyclic GMP
  • Bradykinin